COMMUNIQUÉS West-GlobeNewswire

Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees

06/06/2024 - 11:28

June 6, 2024 Company announcement No. 20 Incentive program for the Executive Leadership Team 2024-2026 In line with previous year, a new long-term incentive program (LTI) for the Executive Leadership Team covering the [...]

Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat at EASL International Liver Congress 2024

06/06/2024 - 11:00

Denifanstat achieved statistically significant results on primary and secondary liver biopsy endpoints in the ITT population, including both histology endpoints recommended in the FDA draft guidance for accelerated [...]

ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing

06/06/2024 - 11:00

Proceeds to support development of ITM’s targeted radiopharmaceutical pipeline and preparations for potential market launch of phase III lead candidate, ITM-11, as it nears clinical read-out Funds will also enable [...]

Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic Forum

06/06/2024 - 09:00

Press release Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic Forum Qubit Pharmaceuticals joins the prestigious community of 100 disruptive technology startups. Over the [...]

Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence

06/06/2024 - 08:00

UPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a [...]

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

06/06/2024 - 07:00

● GABAB PAM: Selection of drug candidates under Indivior collaboration expected by end of Q2 2024 . Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN [...]

EUROAPI reaches major Health IPCEI milestone with official notification from European Commission

06/06/2024 - 07:00

Press Release Paris – June 6, 2024 – EUROAPI has received official notification from the European Commission that the Company has been selected as one of the 13 companies eligible to share up to EUR 1 billion in total [...]

EUROAPI franchit une étape majeure du PIIEC Santé avec la notification officielle de la Commission européenne

06/06/2024 - 07:00

Communiqué de presse Paris – Le 6 juin 2024 – EUROAPI a reçu la notification officielle de la Commission européenne selon laquelle l’entreprise fait partie des 13 sélectionnées pour se partager jusqu’à 1 milliard d’ [...]

Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024

06/06/2024 - 07:00

Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024 “alfapump implantation significantly improved quality of life and showed similar safety outcomes compared to a [...]

Annexon Announces Pricing of $125 Million Underwritten Public Offering

06/06/2024 - 05:04

BRISBANE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

06/06/2024 - 01:53

SAN FRANCISCO, June 05, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and [...]

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

05/06/2024 - 23:46

HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology [...]

Monthly information on share capital and company voting rights

05/06/2024 - 22:30

(Article 223-16 of General Regulation of the French financial markets authority) PARIS, June 05, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

05/06/2024 - 22:30

(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 05 juin 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]

DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

05/06/2024 - 22:30

Châtillon, France, June 5, 2024 DBV Technologies to Participate in the Goldman Sachs 45 th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a [...]

DBV Technologies participera à la 45e conférence annuelle Goldman Sachs Global Healthcare

05/06/2024 - 22:30

Châtillon, France, le 5 juin (22 :30 CEST) 2024 DBV Technologies participera à la 45e conférence annuelle Goldman Sachs Global Healthcare DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— [...]

AVITA Medical Achieves Milestone with First Case Using RECELL GO

05/06/2024 - 22:25

Joseph M. Still Burn Center at Doctors Hospital of Augusta first to treat a patient using AVITA Medical’s FDA-Approved RECELL GO System for thermal burn wounds and full-thickness skin defects VALENCIA, Calif., June 05, [...]

Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference

05/06/2024 - 22:15

WALTHAM, Mass. and DUBLIN, June 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to [...]

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

05/06/2024 - 22:09

SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company [...]